Introduction: The amalgamation of novel drug delivery techniques and potential drugs is considered the most promising tool for the treatment of diseases. In our study, we have employed N-isopropyl acrylamide, N-vinyl pyrrolidone, and acrylic acid (NIPAAM-VP-AA) copolymeric nanoparticles for delivering Ipomoea turpethum root extract. I. turpethum is a perennial herb (Convolvulaceae family) and has been used as medicine for ages. The present study was conducted to evaluate the safety of I. turpethum root extract-loaded NIPAAM-VP-AA polymeric nanoparticles (NVA-IT) in Wistar rats.Methods: An acute oral toxicity study was conducted in accordance with OECD guidelines 423 for the testing of chemicals. Different doses of NVA-IT i.e., 5 mg/kg, 50 mg/kg, 300 mg/kg, and 2000 mg/kg were administered to female Wistar rats in a stepwise manner using oral gavage. The toxicity signs were thoroughly observed for the next 14 days. At the end of the study, the blood and vital organs were harvested for hematological, biochemical, and histopathological studies.Result: No mortality or pathological anomalies were observed even at the highest dose which exemplifies that the lethal dose would be more than 2000 mg/kg body weight (GSH category 5). Behavioral changes, biochemical parameters, and histopathology of vital organs were normal after NVA-IT administration.Conclusion: This study demonstrated that NVA-IT nanoparticles are non-toxic and can be considered for therapeutic use in different diseases, such as inflammation, CNS diseases, Cancer, etc.
Diabetes mellitus is a metabolic disorder with a common denominator of hyperglycemia, arising from a variety of pathogenic mechanisms. The study aimed to evaluate the drug utilization pattern of anti-diabetic drugs in type 2 diabetic patients and to observe the efficacy associated with anti-diabetic therapy. A prospective observational study was carried out in diabetic patients visiting the department of general medicine in a tertiary care teaching hospital over six months. The patients diagnosed with Type 2 diabetes mellitus were identified, and all the demographic details, drug prescriptions, and clinical data of patients were collected and documented in a suitably designed case report form. Based upon the study criteria, 100 people were enrolled in the study. Among the majority of study subjects, 57% were female and 43% were males. The large numbers of diabetic patients were between the age group of 41- 60yrs. Hypertension was the most common comorbid condition. The prescription pattern showed that the majority of patients were prescribed dual therapy and about 48%, Metformin was largely prescribed anti-diabetic drug in all the prescriptions. Among combinations, metformin with glimepiride was frequently prescribed. The present study helped to find out current drug utilization patterns of oral anti-diabetic drugs with different comorbidities concerning diagnosis. Among all the anti-diabetic drugs, metformin was most commonly prescribed. In second-generation sulfonylureas, glimepiride was most commonly prescribed. The practice of metformin monotherapy is limited and it is frequently prescribed in combination with other anti-diabetic drugs. The study also highlights the need for comprehensive management of diabetic patients, including lifestyle changes, dietary control, hypoglycemic agents, cardiovascular prevention, treatment of complications, and comorbidity. Therefore, through the drug utilization patterns, attempts can be made to improve the quality and efficiency of drug therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.